Article Details
Retrieved on: 2022-01-20 10:44:11
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Theravance Biopharma Inc. (NASDAQ: TBPH) enrolls the first patient in the study evaluating YUPELRI in COPD. Recent Post ...
Article found on: biopharmajournal.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here